Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Dividend

Jagsonpal Pharmaceuticals Dividend

Jagsonpal Pharmaceuticals Limited has recommended a dividend of Rs. 4/- (200%) per equity share for the financial year ended March 31, 2026. The dividend is subject to shareholder approval at the upcoming 47th Annual General Meeting. Record and payment dates will be announced separately.

Source

NSE filing, NSE: JAGSNPHARM. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Jagsonpal Pharmaceuticals Ltd: key numbers

Share price
₹224.46
Market cap
₹1,480 Cr
Revenue (annual)
₹287.2 Cr
Net profit (annual)
₹43.08 Cr
P/E (TTM)
32.5×Sector 46.1×
Promoter holding
68.81%-0.24% QoQ
FII holding
2.13%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Jagsonpal Pharmaceuticals Ltd

All →

Other dividend announcements

All →